Overview

NMR metabolomics employs nuclear magnetic resonance spectroscopy to identify and quantify metabolites in complex biological mixtures. NMR detects atomic nuclei (primarily 1H and 13C) that possess spin, producing spectra in which each metabolite generates a characteristic pattern of chemical shifts and coupling constants. The key strengths of NMR for metabolomics are its inherent quantitative nature — signal intensity is directly proportional to concentration — its excellent reproducibility across laboratories and instruments, and its non-destructive, non-biased detection that requires no prior derivatization or separation.

Methods

1H NMR is the workhorse of NMR metabolomics, providing a global view of all hydrogen-containing metabolites in a sample with typical limits of detection in the low micromolar range. Spectral preprocessing includes phase correction, baseline correction, chemical shift referencing, and water signal suppression. Binning or bucketing divides the spectrum into small chemical shift windows to reduce dimensionality and account for minor shift variations. Targeted profiling fits pure compound spectra from libraries to the experimental spectrum, enabling identification and quantification of known metabolites. Two-dimensional NMR methods such as HSQC and TOCSY resolve overlapping signals by adding a second spectral dimension, facilitating the identification of unknowns.

Applications

NMR metabolomics is widely applied in clinical diagnostics, particularly for the screening of inborn errors of metabolism in urine and plasma. It is used in toxicology to identify metabolic signatures of drug-induced organ damage, in food science for authenticity testing, and in plant biology for chemotaxonomy. The method draws on NMR spectroscopy principles, complements mass spectrometry-based approaches, and provides quantitative data that enrich metabolic pathway analysis.